MANA 466 Lecture Notes - Lecture 3: Corporate Social Responsibility, Novo Nordisk

• School: Concordia University
• Department: Management
• Course: MANA 466
• Professor: Jisun Y U

Document Summary

Lot of questions in this section but few answers. In order to have high return on investment, Problem typically when they are producing a new drug, they have to go through four phases to get that new product approved by government agency. Nowadays, many companies are doing clinical trials in developing countries, such as india. Usually people are more in need and they are willing to do anything to get help from big companies. Regulations are more lenient and less strict so they are able to abuse their power. In developing countries, there are easy access to patients at a low costs. It may not be necessarily a problem because lower cost of the company and people are treated. People are less aware and they might have bad side effects in the future. They"re not as caution. in an experiment setting, there should be a treatment group and placebo group.